GlassScriptPhysician profile
Andrew Meagher
NPI 1073982401
$9,167.85
in general payments reported to CMS, 2019-2025
11 companies · $620 in 2025
The $620 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.61 · 2020: $32.39 · 2021: $828 · 2022: $1,583 · 2023: $746 · 2024: $5,342 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,500 · Food and Beverage: $2,606 · Travel and Lodging: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,500.00 |
| Food and Beverage | $2,605.74 |
| Travel and Lodging | $602.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,075.51 | 2022-2025 | |
| Alcon Vision LLC | $1,612.80 | 2022-2025 | Rocklatan, Hydrus Microstent, Wavelight Refractive Suite |
| Bausch & Lomb Americas INC. | $1,137.88 | 2022-2025 | Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $309.86 | 2019-2021 | |
| Allergan, INC. | $298.94 | 2020-2022 | |
| Aerie Pharmaceuticals, INC. | $181.03 | 2021 | |
| Oyster Point Pharma, INC. | $149.53 | 2024 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $124.74 | 2022 | |
| Kala Pharmaceuticals, INC. | $124.74 | 2021 | |
| Glaukos Corporation | $104.91 | 2024 | Istent Inject Trabecular Micro-Bypass System, Radius |
| Thea Pharma INC. | $47.91 | 2024 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Meagher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.